학술논문

Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
Document Type
Article
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, 2023, 64(12):1992-2001)
Subject
Language
English
ISSN
10292403
10428194